TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Berberine on Hormonal and Metabolic Features in Obese Women With PCOS
Brief Summary: Berberine has showed effective in lowering blood sugar levels in db/db mice and anti-dyslipidemia in human.Studies on the effect of berberine on metabolic and hormonal features of women with polycystic ovary syndrome (PCOS) are lacking.The objective of this study is to examine the effect of Berberine metabolic and hormonal parameters and insulin resistance in obese patients with PCOS.


Options:
A: Arm Label: Berberine; Type: EXPERIMENTAL; Interventions: Drug: Berberine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Berberine; Assigned to Arm(s): Berberine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Letrozole -Berberine; Type: EXPERIMENTAL; Interventions: Drug: Letrozole -Berberine | Arm Label: Letrozole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole | Arm Label: Berberine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Berberine | Intervention Type: DRUG; Name: Letrozole -Berberine; Assigned to Arm(s): Letrozole -Berberine | Intervention Type: DRUG; Name: Letrozole; Assigned to Arm(s): Letrozole | Intervention Type: DRUG; Name: Berberine; Assigned to Arm(s): Berberine
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clomiphene citrate | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole | Intervention Type: DRUG; Name: Clomiphene citrate; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Letrozole; Assigned to Arm(s): B
D: Arm Label: Crispbread; Type: EXPERIMENTAL; Interventions: Behavioral: Crispbread | Arm Label: Liquid meal replacement; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Crispbread | Intervention Type: BEHAVIORAL; Name: Crispbread; Assigned to Arm(s): Crispbread, Liquid meal replacement

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Berberine on Hormonal and Metabolic Features in Obese Women With PCOS
Brief Summary: Berberine has showed effective in lowering blood sugar levels in db/db mice and anti-dyslipidemia in human.Studies on the effect of berberine on metabolic and hormonal features of women with polycystic ovary syndrome (PCOS) are lacking.The objective of this study is to examine the effect of Berberine metabolic and hormonal parameters and insulin resistance in obese patients with PCOS.


Options:
A: Arm Label: I.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intrauterine insemination, Procedure: infertility | Arm Label: II.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intrauterine insemination, Procedure: infertility | Intervention Type: PROCEDURE; Name: intrauterine insemination; Assigned to Arm(s): I., II. | Intervention Type: PROCEDURE; Name: infertility; Assigned to Arm(s): I., II.
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: pentoxifylline | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: pentoxifylline; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
C: Arm Label: Coenzyme Q10/CC group; Type: EXPERIMENTAL; Interventions: Drug: Coenzyme Q10, Drug: clomiphene citrate | Arm Label: CC alone group; Type: ACTIVE_COMPARATOR; Interventions: Drug: clomiphene citrate | Intervention Type: DRUG; Name: Coenzyme Q10; Assigned to Arm(s): Coenzyme Q10/CC group | Intervention Type: DRUG; Name: clomiphene citrate; Assigned to Arm(s): CC alone group, Coenzyme Q10/CC group
D: Arm Label: Berberine; Type: EXPERIMENTAL; Interventions: Drug: Berberine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Berberine; Assigned to Arm(s): Berberine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Berberine on Hormonal and Metabolic Features in Obese Women With PCOS
Brief Summary: Berberine has showed effective in lowering blood sugar levels in db/db mice and anti-dyslipidemia in human.Studies on the effect of berberine on metabolic and hormonal features of women with polycystic ovary syndrome (PCOS) are lacking.The objective of this study is to examine the effect of Berberine metabolic and hormonal parameters and insulin resistance in obese patients with PCOS.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: pentoxifylline | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: pentoxifylline; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
B: Arm Label: N-Acetylcysteine; Type: EXPERIMENTAL; Interventions: Drug: N-Acetylcysteine | Arm Label: L-carnitine; Type: ACTIVE_COMPARATOR; Interventions: Drug: L-carnitine | Intervention Type: DRUG; Name: N-Acetylcysteine; Assigned to Arm(s): N-Acetylcysteine | Intervention Type: DRUG; Name: L-carnitine; Assigned to Arm(s): L-carnitine
C: Arm Label: I.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intrauterine insemination, Procedure: infertility | Arm Label: II.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intrauterine insemination, Procedure: infertility | Intervention Type: PROCEDURE; Name: intrauterine insemination; Assigned to Arm(s): I., II. | Intervention Type: PROCEDURE; Name: infertility; Assigned to Arm(s): I., II.
D: Arm Label: Berberine; Type: EXPERIMENTAL; Interventions: Drug: Berberine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Berberine; Assigned to Arm(s): Berberine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Berberine on Hormonal and Metabolic Features in Obese Women With PCOS
Brief Summary: Berberine has showed effective in lowering blood sugar levels in db/db mice and anti-dyslipidemia in human.Studies on the effect of berberine on metabolic and hormonal features of women with polycystic ovary syndrome (PCOS) are lacking.The objective of this study is to examine the effect of Berberine metabolic and hormonal parameters and insulin resistance in obese patients with PCOS.


Options:
A: Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Drug: HCG | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Drug: HCG | Arm Label: Group 3; Type: EXPERIMENTAL; Interventions: Drug: HCG | Arm Label: Group 4; Type: EXPERIMENTAL; Interventions: Drug: HCG | Intervention Type: DRUG; Name: HCG; Assigned to Arm(s): Group 1, Group 2, Group 3, Group 4
B: Arm Label: Crispbread; Type: EXPERIMENTAL; Interventions: Behavioral: Crispbread | Arm Label: Liquid meal replacement; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Crispbread | Intervention Type: BEHAVIORAL; Name: Crispbread; Assigned to Arm(s): Crispbread, Liquid meal replacement
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clomiphene citrate | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole | Intervention Type: DRUG; Name: Clomiphene citrate; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Letrozole; Assigned to Arm(s): B
D: Arm Label: Berberine; Type: EXPERIMENTAL; Interventions: Drug: Berberine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Berberine; Assigned to Arm(s): Berberine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop
Brief Summary: The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.


Options:
A: Arm Label: Ankle-Foot Orthosis (AFO); Type: ACTIVE_COMPARATOR; Interventions: Other: Ankle-Foot Orthosis (AFO) | Arm Label: WalkAide; Type: ACTIVE_COMPARATOR; Interventions: Device: WalkAide | Intervention Type: DEVICE; Name: WalkAide; Assigned to Arm(s): WalkAide | Intervention Type: OTHER; Name: Ankle-Foot Orthosis (AFO); Assigned to Arm(s): Ankle-Foot Orthosis (AFO)
B: Arm Label: Ankle-foot orthosis (AFO) Control Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Ankle-foot orthosis | Arm Label: Ness L300 Treatment Group; Type: EXPERIMENTAL; Interventions: Device: Ness L300 | Intervention Type: DEVICE; Name: Ness L300; Assigned to Arm(s): Ness L300 Treatment Group | Intervention Type: DEVICE; Name: Ankle-foot orthosis; Assigned to Arm(s): Ankle-foot orthosis (AFO) Control Group
C: Arm Label: IpsiHand; Type: EXPERIMENTAL; Interventions: Device: IpsiHand Device | Intervention Type: DEVICE; Name: IpsiHand Device; Assigned to Arm(s): IpsiHand
D: Arm Label: Device-assisted rehabilitation; Type: EXPERIMENTAL; Interventions: Device: Electrical Stimulation; Rehabilitation Robot | Intervention Type: DEVICE; Name: Electrical Stimulation; Rehabilitation Robot; Assigned to Arm(s): Device-assisted rehabilitation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Organized Self-Management Support Services for Chronic Depression
Brief Summary: The purpose is to test the effectiveness of an organized care program for chronic or recurrent depression. Using a two-arm design, the investigators will randomly assign 300 participants with chronic or recurrent depression to one of two conditions: continued usual care (UC); or an 18-month organized treatment program focused on outreach and engagement, including a weekly group self-management training program, monthly visits with a psychotherapist (in-person or by telephone), and optional one-on-one visits with a peer support specialist. All intervention components are intended as adjuncts to any existing depression treatment (usually antidepressant medication) provided by participants' regular providers.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine, Drug: Citalopram | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Venlafaxine | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine, Behavioral: Cognitive Behavioral Therapy (CBT), Drug: Citalopram | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: Venlafaxine, Behavioral: Cognitive Behavioral Therapy (CBT) | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Venlafaxine; Assigned to Arm(s): 2, 4 | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy (CBT); Assigned to Arm(s): 3, 4 | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): 1, 3
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: 2; Type: OTHER; Interventions: Behavioral: Non Contingent Control Condition | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Non Contingent Control Condition; Assigned to Arm(s): 2
C: Arm Label: Mindfulness-based Cognitive Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based Cognitive Therapy, Biological: Standard psychiatric care | Arm Label: CBASP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: The Cognitive Behavioral Analysis System of Psychotherapy, Biological: Standard psychiatric care | Arm Label: Treatment-as-usual; Type: ACTIVE_COMPARATOR; Interventions: Biological: Standard psychiatric care | Intervention Type: BEHAVIORAL; Name: Mindfulness-based Cognitive Therapy; Assigned to Arm(s): Mindfulness-based Cognitive Therapy | Intervention Type: BEHAVIORAL; Name: The Cognitive Behavioral Analysis System of Psychotherapy; Assigned to Arm(s): CBASP | Intervention Type: BIOLOGICAL; Name: Standard psychiatric care; Assigned to Arm(s): CBASP, Mindfulness-based Cognitive Therapy, Treatment-as-usual
D: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: organized care program for chronic or recurrent depression | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: organized care program for chronic or recurrent depression; Assigned to Arm(s): Intervention Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stop Antibiotics on Procalcitonin Guidance Study
Brief Summary: This is a randomized controlled trial comparing standard-of-care therapy of infections in critically ill patients with a procalcitonin-guided approach evaluating efficacy (antibiotics consumption) and safety (mortality).


Options:
A: Intervention Type: BEHAVIORAL; Name: No antibiotics if se-procalcitonin is below stated limit; Assigned to Arm(s): N/A
B: N/A
C: Arm Label: Group 1 - C-reactive protein (CRP) guided ab therapy; Type: EXPERIMENTAL; Interventions: Other: C-reactive protein guided antibiotic therapy | Arm Label: Group 2 - procalcitonin (PCT) guided ab therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Procalcitonin guided antibiotic therapy | Intervention Type: OTHER; Name: C-reactive protein guided antibiotic therapy; Assigned to Arm(s): Group 1 - C-reactive protein (CRP) guided ab therapy | Intervention Type: OTHER; Name: Procalcitonin guided antibiotic therapy; Assigned to Arm(s): Group 2 - procalcitonin (PCT) guided ab therapy
D: Arm Label: procalcitonin-guidance; Type: ACTIVE_COMPARATOR; Interventions: Other: procalcitonin-guidance | Arm Label: standard-of-care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: procalcitonin-guidance; Assigned to Arm(s): procalcitonin-guidance

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stop Antibiotics on Procalcitonin Guidance Study
Brief Summary: This is a randomized controlled trial comparing standard-of-care therapy of infections in critically ill patients with a procalcitonin-guided approach evaluating efficacy (antibiotics consumption) and safety (mortality).


Options:
A: Arm Label: SelPCT; Type: ACTIVE_COMPARATOR; Interventions: Drug: sodium-selenite, Procedure: Procalcitonin guided therapy | Arm Label: SelKon; Type: ACTIVE_COMPARATOR; Interventions: Drug: sodium-selenite | Arm Label: PlacPCT; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Procedure: Procalcitonin guided therapy | Arm Label: PlacKon; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: sodium-selenite; Assigned to Arm(s): SelKon, SelPCT | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): PlacKon, PlacPCT | Intervention Type: PROCEDURE; Name: Procalcitonin guided therapy; Assigned to Arm(s): PlacPCT, SelPCT
B: Intervention Type: PROCEDURE; Name: PCT measurement; Assigned to Arm(s): N/A
C: Arm Label: procalcitonin-guidance; Type: ACTIVE_COMPARATOR; Interventions: Other: procalcitonin-guidance | Arm Label: standard-of-care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: procalcitonin-guidance; Assigned to Arm(s): procalcitonin-guidance
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Procalcitonin guided strategy | Intervention Type: PROCEDURE; Name: Procalcitonin guided strategy; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Brief Summary: The purpose of this study is to investigate the efficacy and safety of once daily tadalafil when taken with finasteride as a treatment for men with signs and symptoms of Benign Prostatic Hyperplasia and demonstrable prostate enlargement.


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Arm Label: 5; Type: ACTIVE_COMPARATOR; Interventions: Drug: tadalafil | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: tadalafil; Assigned to Arm(s): 5 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 1
B: Intervention Type: DRUG; Name: Viagra; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A
C: Arm Label: Tadalafil; Type: EXPERIMENTAL; Interventions: Drug: Tadalafil, Drug: Finasteride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Finasteride | Intervention Type: DRUG; Name: Tadalafil; Assigned to Arm(s): Tadalafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Finasteride; Assigned to Arm(s): Placebo, Tadalafil
D: Arm Label: 5 milligrams (mg) Tadalafil; Type: EXPERIMENTAL; Interventions: Drug: Tadalafil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tadalafil; Assigned to Arm(s): 5 milligrams (mg) Tadalafil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vitamin D Status: Relative Efficacy of Vitamins D2 and D3
Brief Summary: Vitamin D2 in chronic dosing will produce less of an elevation of serum 25(OH)D than will the same dose of vitamin D3.


Options:
A: Arm Label: Intervention; Type: N/A; Interventions: Behavioral: educational/counseling intervention, Behavioral: therapeutic dietary intervention | Arm Label: Control; Type: N/A; Interventions: Behavioral: therapeutic dietary intervention | Intervention Type: BEHAVIORAL; Name: educational/counseling intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: therapeutic dietary intervention; Assigned to Arm(s): Control, Intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: calcium supplementation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: calcium and vitamin D3 supplementation | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: calcium supplementation; Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: calcium and vitamin D3 supplementation; Assigned to Arm(s): 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): 3
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: cholecalciferol (vitamin D) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: cholecalciferol (vitamin D) | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol (vitamin D); Assigned to Arm(s): 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: cholecalciferol (vitamin D); Assigned to Arm(s): 2
D: Arm Label: vitamin D2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin D2 | Arm Label: vitamin D3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D2; Assigned to Arm(s): vitamin D2 | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D3; Assigned to Arm(s): vitamin D3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vitamin D Status: Relative Efficacy of Vitamins D2 and D3
Brief Summary: Vitamin D2 in chronic dosing will produce less of an elevation of serum 25(OH)D than will the same dose of vitamin D3.


Options:
A: Arm Label: vitamin D2; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin D2 | Arm Label: vitamin D3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D2; Assigned to Arm(s): vitamin D2 | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D3; Assigned to Arm(s): vitamin D3
B: Intervention Type: DRUG; Name: cholecalciferol; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Physiotherapy; Assigned to Arm(s): N/A
C: Arm Label: Calcitriol; Type: EXPERIMENTAL; Interventions: Drug: Calcitriol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Calcitriol | Intervention Type: DRUG; Name: Calcitriol; Assigned to Arm(s): Calcitriol, placebo
D: Arm Label: vitamin D oil; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin D | Arm Label: placebo oil; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: vitamin D | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin D; Assigned to Arm(s): placebo oil, vitamin D oil

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Modified Ultrafiltration Improves Inflammatory Response and Cardiopulmonary Function After CABG Procedures?
Brief Summary: The inflammatory response after cardiac surgery increases mortality and morbidity. Modified ultrafiltration (MUF) has been shown to decrease the post-cardiac surgery inflammatory response, to improve respiratory function, and cardiac performance in pediatric patients; however, this approach has not been well established in adults. The investigators therefore hypothesized that MUF can decrease the post-cardiac surgery inflammatory response and can improve cardiopulmonary function in adults.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: epoetinum | Intervention Type: DRUG; Name: epoetinum; Assigned to Arm(s): 2
B: Arm Label: Placebo; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Modified Ultrafiltration; Type: EXPERIMENTAL; Interventions: Procedure: Modified Ultrafiltration | Intervention Type: PROCEDURE; Name: Modified Ultrafiltration; Assigned to Arm(s): Modified Ultrafiltration
C: Arm Label: Sevoflurane Group; Type: N/A; Interventions: Drug: Sevoflurane | Arm Label: Not Sevoflurane Group; Type: N/A; Interventions: N/A | Intervention Type: DRUG; Name: Sevoflurane; Assigned to Arm(s): Sevoflurane Group
D: Arm Label: HOE 140; Type: EXPERIMENTAL; Interventions: Drug: HOE 140 | Arm Label: Aminocaproic Acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aminocaproic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: HOE 140; Assigned to Arm(s): HOE 140 | Intervention Type: DRUG; Name: Aminocaproic Acid; Assigned to Arm(s): Aminocaproic Acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B